Inactive

The National Center for Advancing Translational Sciences (NCATS) intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to R&D Systems I... The National Center for Advancing Translational Sciences (NCATS) intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to R&D Systems Inc., 614 McKinley Place NE, Minneapolis, MN 55413 for 5mg of recombinant West Nile Virus NS2B-NS3 protease. The anticipated award date is 7/22/2022. This acquisition is non-competitive due to the requirement to ensure compatibility in all aspects (form, fit, and function) to ensure consistency and continuity of results in ongoing scientific studies. See the attached combined synopsis/solicitation for full details.